VSC Stock Price | 4SC AG P/E, Revenue, EPS, & Forecasts

4SC AG • VSC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About 4SC AG

Ticker

VSC

Trading on

ISIN

DE000A3E5C40

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Jason Loveridge B.Sc., FRSM, Ph.D.

Headquarters

Fraunhoferstrasse 22, Planegg, undefined, Germany, 82152

Employees

Website

4sc.com

4SC AG, a biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany. Its product Resminostat, an orally administered histone deacetylase inhibitor for the treatment of cutaneous T-cell lymphoma, which is in clinical development stage. The company also out-licenses its products to pharma and biotech companies. The company was founded in 1997 and is headquartered in Planegg, Germany.

Metrics

BasicAdvanced

Market cap

€76.4M

P/E ratio

EPS

-€0.74

Dividend Yield

0.00%

Beta

1.72

Forward P/E ratio

EBIDTA

€-7.1M

Ex dividend date

Price & volume

Market cap

€76.4M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

€0.00

Dividend yield

0.00%

Forward dividend per share

€0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

212.7

Price to book

25.01

Earnings

EPS

-€0.74

EPS estimate (current quarter)

€0.00

EPS estimate (next quarter)

€0.00

EBITDA

€-7.1M

Revenues (TTM)

€0.4M

Revenues per share (TTM)

€0.04

Technicals

Beta

1.72

52-week High

€9.70

52-week Low

€2.07

50-day moving average

€4.62

200-day moving average

€4.92

Short ratio

Short %

0.00%

Management effectiveness

ROE (TTM)

154.90%

ROA (TTM)

51.05%

Profit margin

0.00%

Gross profit margin

€0.3M

Operating margin

2,169.23%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

43.30%

Share stats

Outstanding Shares

10.1M

Float

2.8M

Insiders %

72.44%

Institutions %

0.00%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-€0.65

Q2 • 20Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

0.00%

Q1 • 23

0.00%

Q2 • 23

NaN%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

€13.4M

€4.7M

35.47%

Q2 • 23

€9.4M

€4.4M

46.27%

Q4 • 23

29.64%

8.21%

30.47%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

Q2 • 23

Q4 • 23

NaN%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a 4SC AG share?

4SC AG shares are currently traded for undefined per share.

How many shares does 4SC AG have?

4SC AG currently has 10.1M shares.

Does 4SC AG pay dividends?

No, 4SC AG doesn't pay dividends.

What is 4SC AG 52 week high?

4SC AG 52 week high is €9.70.

What is 4SC AG 52 week low?

4SC AG 52 week low is €2.07.

What is the 200-day moving average of 4SC AG?

4SC AG 200-day moving average is €4.92.

Who is 4SC AG CEO?

The CEO of 4SC AG is Dr. Jason Loveridge B.Sc., FRSM, Ph.D..

How many employees 4SC AG has?

4SC AG has 15 employees.

What is the market cap of 4SC AG?

The market cap of 4SC AG is €76.4M.

What is the P/E of 4SC AG?

The current P/E of 4SC AG is null.

What is the EPS of 4SC AG?

The EPS of 4SC AG is -€0.74.

What is the PEG Ratio of 4SC AG?

The PEG Ratio of 4SC AG is 0.